180 Life Sciences Corp (FRMM)
Drugs • Health Care
Percentage
Change
| Mar 18 | Apr 19 | Apr 20 | Jul 21 | Mar 22 | Mar 23 | Mar 24 | Mar 25 | Apr 26 | |
|---|---|---|---|---|---|---|---|---|---|
Net Income to Common | -14 | -451 | |||||||
Preferred Dividends | 8 | 0 | |||||||
Net Income | -6 | -451 | |||||||
Profit | -6 | -451 | |||||||
Net Income Discontinued | 0 | -7 | |||||||
Net Income Continuing | -6 | -444 | |||||||
Income Tax Expense | 0 | 0 | |||||||
Pretax Income | -6 | -444 | |||||||
Total Non-operating Income | -0 | -210 | |||||||
Operating Income | -6 | -233 | |||||||
Total Revenue | 0 | 7 | |||||||
Total Costs and Expenses | -6 | -240 | |||||||
Operating Expenses | -6 | -240 | |||||||
Research and Development Expenses | -1 | 0 | |||||||
Selling, General & Administrative Expenses | -4 | -240 | |||||||
Other Operating Expenses | -1 | 0 |